A
Anvajo
Biotech & Life Sciences · Dresden, Germany · Founded 2016
A Dresden-based technology company that develops, manufactures and sells innovative solutions for the analysis of liquids MoreLess
Anvajo is a pioneering developer and manufacturer of point of care solutions for laboratory diagnostic testing of liquids. The company's flagship product, the fluidlab, is a compact, handheld device that combines microscopy and spectrometry to provide rapid, accurate, and quantitative analysis of various fluids, including blood, urine, sperm, and water. This innovative platform is designed to be easy to use, portable, and cost-effective, making it ideal for field usage in structurally underdeveloped regions. Anvajo primarily serves healthcare providers, laboratories, and research institutions, offering them a reliable and efficient tool for fluid diagnostics. The company's business model revolves around the sale of the fluidlab devices and associated consumables, generating revenue through direct sales and partnerships. By addressing the need for accessible and precise diagnostic tools, Anvajo is positioned in the growing market of point of care testing technologies.
Keywords: point of care, fluid diagnostics, microscopy, spectrometry, handheld device, healthcare, laboratory testing, portable, quantitative analysis, innovative platform.
Company overview
Anvajo company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2016
- Headquarters
- Dresden, Germany
- Employees
- 50
- Open positions
- 1
- Dealroom signal
- 67.9
Valuation & funding
Anvajo funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Dec 2024 | — | — | Die BrückenKöpfe · Bold Ventures · FSF Beteiligungs · Medice | — |
| EARLY VC✓Equity / VC | Oct 2022 | $19M | $78M | Think.Health · Medice · Johnson Venture Partners · Elber Beteiligungen | ↗ |
| SUPPORT PROGRAM✓Other financing | Jan 2022 | $0 | — | EIT Health | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | Profit | Margin |
|---|---|---|---|---|
| 2026 | $2M | 0% | −$5.1M | -257.2% |
| 2025 | $2M | 0% | −$5.1M | -257.2% |
| 2024 | $2M | 0% | −$5.1M | -257.2% |
| 2023 | $2M | +15.9% | ||
| 2022 | $1.7M | +23.2% | ||
| 2021 | $1.4M | -8% | ||
| 2020 | $1.5M | — |
Growth signals
Anvajo website traffic
Latest recorded traffic for Anvajo is 3.3K monthly website visits, up 4025% over the last three months. Anvajo's team grew 0% over the past year.
Hiring
Open positions at Anvajo
Current openings linked to this company in Dealroom.
Comparisons
Anvajo compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Anvajo's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Anvajo has talent and traffic
team presence
In the news
Latest news about Anvajo
Recent press, funding announcements, and product moves mentioning Anvajo — open to read from the original sources.
Market sentiment
What the market is saying about Anvajo
An AI-synthesized read of the highest-engagement posts about Anvajo on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Anvajo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.